The history of clozapine and its emergence in the US market: a review and analysis.
about
Clozapine: a review of clinical practice guidelines and prescribing trendsClozapine for psychotic disorders in adults with intellectual disabilitiesClozapine for psychotic disorders in adults with intellectual disabilitiesObesity in children with autism spectrum disorderWhat can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FutureEpigenetic signaling in schizophreniaObesity Prevention for Children with Developmental Disabilities.Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Update on the role of antipsychotics in the treatment of Tourette syndrome.When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of lifeIdentification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trialWhat do we know about neuropsychological aspects of schizophrenia?Group II metabotropic glutamate receptors and schizophrenia.Where to position clozapine: re-examining the evidence.Genetics of antipsychotic-induced side effects and agranulocytosis.Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?Valley of death: A proposal to build a "translational bridge" for the next generation.Using Intermediate Cognitive Endpoints to Facilitate Translational Research in Psychosis.Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.Genome-wide association study of lymphoblast cell viability after clozapine exposure.Clozapine as a Model for Antipsychotic Development.The story of antipsychotics: Past and present.Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.Changes for clozapine monitoring in the United States.Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans.Optimizing clozapine through clinical decision making.Effectiveness and safety of rapid clozapine titration in schizophrenia.Risk Evaluation and Mitigation Strategy for ClozapineCurrent Concepts and Treatments of Schizophrenia
P2860
Q21260307-2763FF23-8110-4F2A-9136-CFAE48706534Q24187048-937BAAD9-157C-4648-A83B-106C316A0FB5Q24202342-E2078617-4E1B-4FB4-8193-6B06D6DE0121Q26860363-0919DB7D-051A-411F-B920-FE68826F3254Q28083481-542550E7-8F43-46D4-9DE6-628E46B281A0Q28394341-E3A7C797-AE64-445D-9C4B-D73445CCBFA3Q34482708-30BC6EB7-61A9-49D1-9AEF-85DB750F4EFEQ34711543-DE21A5C9-1403-483B-BEB9-960A3DAA0C89Q35071909-F5C549DA-F450-44FF-A353-2BA5B2D5D978Q35839717-515224DC-6730-4982-A69E-D90B5879E0A5Q35868866-8D471625-8601-46E1-A725-4D40C0737DA1Q36715883-75CCB66B-6C55-4E6B-9F58-76C14EFB04B4Q37011466-28817516-CFC3-4055-A91F-782B74E32029Q37147674-B2EE5A54-BCFD-40F1-83A1-9074235A84EEQ37212118-8CEE41CD-1A38-4AAF-BADD-905CADC172C7Q37350409-02B62826-C750-47BE-8674-56E585B625F8Q37473779-6A61B4EE-985C-4DA4-9DD9-14DE5207C481Q37801988-1B436DEB-E0A2-4296-A6EF-792704F416CCQ37845227-D1B3207B-10FD-41CA-8D87-5D8F42C4818EQ37862242-403418FB-02A5-44A9-8D0B-270C910CE66DQ38062444-90BF414C-7C57-47BB-8D0E-6D47D4C180A2Q38375627-9C780447-4141-4B4D-9029-F89E2FF25FF9Q38670526-A3DAC129-B1AB-42A3-8BE9-8843F18546FEQ38840211-31087C6C-0CEC-4496-A3C8-12AEA98A0753Q38967700-FB564D0C-5CA5-4705-A570-6A6569AF4A54Q39400094-7EBB0087-9C27-4DBA-AA95-53B603BCEBBDQ42019820-A2BE5473-3889-43CE-A578-E39709923C64Q45064849-86C714CC-48CB-45D4-BA41-0182E8068A48Q48032137-75F37522-C8DF-4D76-AD98-9C8F14EBD77EQ50481966-0BA5C430-D8B3-4FF4-A377-FC12DDFAB209Q51792951-BC856E04-CAC0-4D71-B2E8-3439D2EF7851Q54417865-44123A51-443F-479B-A1D6-BE38E016D2BFQ57820161-359C4308-A41B-4853-8463-97256791E7F6Q58693044-3CB84A2B-0FF4-47F3-B65C-BF607AC8CB08
P2860
The history of clozapine and its emergence in the US market: a review and analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The history of clozapine and its emergence in the US market: a review and analysis.
@ast
The history of clozapine and its emergence in the US market: a review and analysis.
@en
The history of clozapine and its emergence in the US market: a review and analysis.
@nl
type
label
The history of clozapine and its emergence in the US market: a review and analysis.
@ast
The history of clozapine and its emergence in the US market: a review and analysis.
@en
The history of clozapine and its emergence in the US market: a review and analysis.
@nl
prefLabel
The history of clozapine and its emergence in the US market: a review and analysis.
@ast
The history of clozapine and its emergence in the US market: a review and analysis.
@en
The history of clozapine and its emergence in the US market: a review and analysis.
@nl
P2860
P356
P1476
The history of clozapine and its emergence in the US market: a review and analysis.
@en
P2093
John Crilly
P2860
P356
10.1177/0957154X07070335
P577
2007-03-01T00:00:00Z